TERREMOTO Trademark

Trademark Overview


On Wednesday, November 30, 2022, a trademark application was filed for TERREMOTO with the United States Patent and Trademark Office. The USPTO has given the TERREMOTO trademark a serial number of 97697582. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 16, 2024. This trademark is owned by TERREMOTO BIOSCIENCES, INC.. The TERREMOTO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceuticals for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; biopharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; bioph...

Drug discovery and development services; computational drug discovery and development services; scientific, medical, biotechnology, biomedical, medicinal chemistry, and pharmaceutical research and development services; scientific and medical testing services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; research, development, discovery and consulting services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; research in the fields of chemistry and medicinal chemistry; medical research; clinical research and development services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; medical and scientific research, namely, conducting and evaluating clinical trials for others; providing information about medical and scientific research; providing scientific information in the fields of medicine, biotechnology, medicinal chemistry, and pharmaceuticals; provision of drug discovery and...
terremoto

General Information


Serial Number97697582
Word MarkTERREMOTO
Filing DateWednesday, November 30, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements


Goods and ServicesPharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceuticals for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; biopharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; biopharmaceuticals for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; medicines for the prevention and treatment of cancer, oncological diseases, disorders and conditions; medicines for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; drugs for the prevention and treatment of cancer, oncological diseases, disorders and conditions; drugs for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; drug compounds for the prevention and treatment of cancer, oncological diseases, disorders and conditions; drug compounds for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; small molecules for the prevention and treatment of cancer, oncological diseases, disorders and conditions; small molecules for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; therapeutics for the prevention and treatment of cancer, oncological diseases, disorders and conditions; therapeutics for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions;
Translation of Words in MarkThe English translation of "TERREMOTO" in the mark is "Earthquake".
Goods and ServicesDrug discovery and development services; computational drug discovery and development services; scientific, medical, biotechnology, biomedical, medicinal chemistry, and pharmaceutical research and development services; scientific and medical testing services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; research, development, discovery and consulting services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; research in the fields of chemistry and medicinal chemistry; medical research; clinical research and development services in the fields of biotechnology, biomedical, medicinal chemistry, and pharmaceuticals; medical and scientific research, namely, conducting and evaluating clinical trials for others; providing information about medical and scientific research; providing scientific information in the fields of medicine, biotechnology, medicinal chemistry, and pharmaceuticals; provision of drug discovery and development information; provision of computational drug discovery information;

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 22, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTERREMOTO BIOSCIENCES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameTERREMOTO BIOSCIENCES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSAN FRANCISCO, CA 94158

Party NameTERREMOTO BIOSCIENCES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158

Trademark Events


Event DateEvent Description
Saturday, September 16, 2023NON-FINAL ACTION WRITTEN
Saturday, December 3, 2022NEW APPLICATION ENTERED
Thursday, December 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 23, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, January 25, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, September 9, 2023ASSIGNED TO EXAMINER
Saturday, September 16, 2023NON-FINAL ACTION E-MAILED
Saturday, September 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 19, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, October 19, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, March 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, June 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 3, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 3, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT